11 – 20 of 660
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Haemophilia B : an illustrative review of current challenges and opportunities
- Contribution to journal › Article
-
Mark
Evaluation of One-Stage Assays for the Monitoring of Recombinant Human Factor IX Padua Activity After Etranacogene Dezaparvovec Gene Therapy
- Contribution to journal › Article
-
Mark
Evaluation of kidney function and damage in patients with hemophilia B—insights from the B-Natural study
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab : Results From the Phase IV HemiNorth 2 Study
- Contribution to journal › Article
-
Mark
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder : Back to the clinical phenotype
- Contribution to journal › Article
-
Mark
Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease—An observational study
- Contribution to journal › Article
-
Mark
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
- Contribution to journal › Article
- 2024
-
Mark
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
- Contribution to journal › Article
-
Mark
Historical perspective on von Willebrand disease
(2024) p.1-6
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Textbook of von Willebrand Disease : Basic and Clinical Aspects
- Book/Report › Anthology (editor)
